摘要
目的探讨康艾注射液能否减轻乳腺癌患者术后化疗的毒副反应。方法随机设计两组乳腺癌术后患者作为研究对象，治疗组（n=47）采用康艾注射液40～60mL加入5％葡萄糖或0．9％生理盐水250～500mL稀释后静脉点滴，1次／d，30d为1个疗程，同时合并全身化疗（AC方案），对照组（n=46）单用化疗。毒副反应按WHO标准评价。结果治疗组比对照组在血液学毒性方面明显下降（P0．01）。结论康艾注射液可减少乳腺癌患者术后化疗的毒副反应，提高患者的生活质量。
Objective To discussion KangAi injection can reduce patients with breast cancer, the adverse reaction of postoperative chemotherapy. Methods design of two groups of patients with breast cancer as the research object：The treatment group （n = 47） KangAi injection by 40 mL - 60 mL to glucose, or 5% 0.9% saline 250 mL to 500 mL diluted bit vein, 1 / d, 30 d for a period of treatment, and at the same time with systemie chemotherapy （AC plan）, and the control group （n = 46）, only with chemotherapy. Adverse reaction according to WHO standard evaluation. Results Treatment group than in the control group in hematology toxicity to decline significantly（P〈0.01）, so as to improve the quality of life. Conclusions Not only KangAi injection can reduce breast cancer patients the adverse reaction of postoperative chemotherapy, hut improve the quality of life of the patients.
出处
《山西大同大学学报（自然科学版）》
2012年第3期55-57,共3页
Journal of Shanxi Datong University(Natural Science Edition)
关键词
康艾注射液
乳腺癌
术后化疗
KangAi injection
breast cancer
postoperative chemotherapy
作者简介
张军（1963-），男，山西大同人，主治医师，研究方向：呼吸系统消化系统肿瘤，乳腺肿瘤。
